Literature DB >> 24119241

Tumour-associated macrophages are associated with vascular endothelial growth factor expression in canine mammary tumours.

T P Raposo1, I Pires2, M I Carvalho1, J Prada2, D J Argyle3, F L Queiroga1,4.   

Abstract

Tumour-associated macrophages (TAMs) have been implicated in carcinogenesis including an important role in angiogenesis. In this study, we describe the relationship between TAMs and angiogenesis in canine mammary tumours (CMT). Formalin-fixed paraffin-embedded CMT samples [(n = 128: malignant (n = 97) and benign (n = 31)] were submitted to immunohistochemical staining to detect MAC387, vascular endothelial growth factor VEGF and CD31 expression. A statistical analysis was carried out to assess possible associations with clinicopathological variables and biological markers of tumour angiogenesis. TAMs, detected by MAC387 expression, were significantly associated with malignant CMT (P < 0.001) and VEGF positive tumours (P = 0.002) and also associated with VEGF expression within malignant CMT (P = 0.043). Associations with clinicopathological variables were found between TAMs and the presence of infiltrative growth (P = 0.031), low tubule formation (P = 0.040) and lymph node metastasis (P = 0.016). The results support the hypothesis that TAMs influence angiogenesis in CMT suggesting TAMs may represent a therapeutic target in this disease.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  breast cancer; canine mammary tumours; prognosis; tumour-associated macrophages

Mesh:

Substances:

Year:  2013        PMID: 24119241     DOI: 10.1111/vco.12067

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  7 in total

1.  A Role for Angiogenesis in Canine Cutaneous Histiocytoma Regression: Insights into an Old Clinical Enigma.

Authors:  Diana Costa; Rita Ferreira; Justina Prada; Felisbina Luisa Queiroga; Paula Rodrigues; Filipe Silva; Isabel Pires
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

2.  Immune Cells and Immunoglobulin Expression in the Mammary Gland Tumors of Dog.

Authors:  Alessandra Sfacteria; Ettore Napoli; Claudia Rifici; Daria Commisso; Giada Giambrone; Giuseppe Mazzullo; Gabriele Marino
Journal:  Animals (Basel)       Date:  2021-04-21       Impact factor: 2.752

3.  Tumour-associated macrophages correlate with microvascular bed extension in colorectal cancer patients.

Authors:  Ilaria Marech; Michele Ammendola; Rosario Sacco; Giuseppe Sammarco; Valeria Zuccalà; Nicola Zizzo; Christian Leporini; Maria Luposella; Rosa Patruno; Gianfranco Filippelli; Emilio Russo; Mariangela Porcelli; Cosmo Damiano Gadaleta; Giovambattista De Sarro; Girolamo Ranieri
Journal:  J Cell Mol Med       Date:  2016-04-22       Impact factor: 5.310

Review 4.  A Comparative Approach of Tumor-Associated Inflammation in Mammary Cancer between Humans and Dogs.

Authors:  Maria Isabel Carvalho; Ricardo Silva-Carvalho; Isabel Pires; Justina Prada; Rodolfo Bianchini; Erika Jensen-Jarolim; Felisbina L Queiroga
Journal:  Biomed Res Int       Date:  2016-12-08       Impact factor: 3.411

5.  Distribution of Glutathione-Stabilized Gold Nanoparticles in Feline Fibrosarcomas and Their Role as a Drug Delivery System for Doxorubicin-Preclinical Studies in a Murine Model.

Authors:  Katarzyna Zabielska-Koczywąs; Anna Wojtalewicz; Ewelina Użarowska; Agata Klejman; Agata Wojtkowska; Izabella Dolka; Marek Wojnicki; Katarzyna Sobczak; Michał Wójcik; Haifa Shen; Mauro Ferrari; Roman Lechowski
Journal:  Int J Mol Sci       Date:  2018-03-29       Impact factor: 5.923

Review 6.  Know Thy Model: Charting Molecular Homology in Stromal Reprogramming Between Canine and Human Mammary Tumors.

Authors:  Enni Markkanen
Journal:  Front Cell Dev Biol       Date:  2019-12-17

7.  Intratumoral CD3+ T-lymphocytes immunoexpression and its association with c-Kit, angiogenesis, and overall survival in malignant canine mammary tumors.

Authors:  Maria Isabel Carvalho; Isabel Pires; Marlene Dias; Justina Prada; Hugo Gregório; Luis Lobo; Felisbina Queiroga
Journal:  Anal Cell Pathol (Amst)       Date:  2015-08-05       Impact factor: 2.916

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.